Elplat oxaliplatin regulatory update

Yakult said Japan approved an sNDA for Elplat oxaliplatin as a postoperative adjuvant chemotherapy in gastric cancer. The product was already approved to treat unresectable advanced or recurrent gastric cancer. ...